HomeCompareMNARF vs JNJ

MNARF vs JNJ: Dividend Comparison 2026

MNARF yields 4.54% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MNARF wins by $7.1K in total portfolio value
10 years
MNARF
MNARF
● Live price
4.54%
Share price
$12.25
Annual div
$0.56
5Y div CAGR
0.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.2K
Annual income
$649.16
Full MNARF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MNARF vs JNJ

📍 MNARF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNARFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNARF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNARF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNARF
Annual income on $10K today (after 15% tax)
$385.57/yr
After 10yr DRIP, annual income (after tax)
$551.79/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $151.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNARF + JNJ for your $10,000?

MNARF: 50%JNJ: 50%
100% JNJ50/50100% MNARF
Portfolio after 10yr
$23.6K
Annual income
$738.47/yr
Blended yield
3.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MNARF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.8
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNARF buys
0
JNJ buys
0
No recent congressional trades found for MNARF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNARFJNJ
Forward yield4.54%3.36%
Annual dividend / share$0.56$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0.6%5.8%
Portfolio after 10y$27.2K$20.0K
Annual income after 10y$649.16$827.78
Total dividends collected$5.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: MNARF vs JNJ ($10,000, DRIP)

YearMNARF PortfolioMNARF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,156$456.34$10,676$355.77+$480.00MNARF
2$12,416$478.65$11,407$389.39+$1.0KMNARF
3$13,786$500.83$12,198$426.53+$1.6KMNARF
4$15,274$522.83$13,056$467.62+$2.2KMNARF
5$16,888$544.61$13,987$513.12+$2.9KMNARF
6$18,636$566.14$14,998$563.56+$3.6KMNARF
7$20,528$587.38$16,098$619.52+$4.4KMNARF
8$22,573$608.31$17,295$681.69+$5.3KMNARF
9$24,782$628.91$18,599$750.82+$6.2KMNARF
10$27,166$649.16$20,022$827.78+$7.1KMNARF

MNARF vs JNJ: Complete Analysis 2026

MNARFStock

The REIT is an unincorporated, open-ended real estate investment trust established under and governed by the laws of the Province of Ontario. The Units of the REIT trade on the Toronto Stock Exchange under the ticker symbol MRG.UN. With a strategic focus on the acquisition of high-quality multi-suite residential properties in Canada and the United States, the REIT maximizes long-term Unit value through active asset and property management. The REIT's portfolio is comprised of 13,275 residential suites (as of October 27, 2020) located in Alberta, Ontario, Colorado, Texas, Louisiana, Illinois, Georgia, Florida, North Carolina, Virginia and Maryland with an appraised value of approximately $3.1 billion at September 30, 2020.

Full MNARF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MNARF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNARF vs SCHDMNARF vs JEPIMNARF vs OMNARF vs KOMNARF vs MAINMNARF vs ABBVMNARF vs MRKMNARF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.